Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Henry Schein, Inc. (NASDAQ:HSICGet Free Report) have been given a consensus rating of “Hold” by the eleven analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $81.73.

Several analysts recently weighed in on the stock. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. SVB Leerink began coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. Piper Sandler reissued an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a research report on Friday. Finally, Evercore ISI upped their price target on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th.

Check Out Our Latest Stock Report on HSIC

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of HSIC. Everett Harris & Co. CA increased its position in Henry Schein by 29.1% in the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock valued at $7,925,000 after acquiring an additional 23,622 shares during the period. KBC Group NV lifted its holdings in shares of Henry Schein by 163.5% during the fourth quarter. KBC Group NV now owns 521,964 shares of the company’s stock worth $39,518,000 after purchasing an additional 323,901 shares during the period. Duality Advisers LP purchased a new position in Henry Schein in the 4th quarter valued at $1,561,000. Sprucegrove Investment Management Ltd. increased its stake in Henry Schein by 14.2% in the 4th quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock valued at $16,693,000 after buying an additional 27,500 shares during the period. Finally, Pzena Investment Management LLC raised its position in Henry Schein by 61.4% during the 4th quarter. Pzena Investment Management LLC now owns 809,558 shares of the company’s stock worth $61,292,000 after buying an additional 307,934 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Trading Up 0.0 %

Shares of NASDAQ HSIC opened at $67.27 on Tuesday. The stock has a fifty day simple moving average of $70.37 and a 200-day simple moving average of $73.10. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $8.61 billion, a PE ratio of 22.73, a PEG ratio of 1.64 and a beta of 0.90.

Henry Schein (NASDAQ:HSICGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same quarter in the prior year, the company earned $1.21 earnings per share. The business’s quarterly revenue was up 3.7% on a year-over-year basis. On average, equities analysts forecast that Henry Schein will post 5.17 earnings per share for the current year.

Henry Schein Company Profile

(Get Free Report

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.